Clinical Trial Update: Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications [Phase 2]

View source ↗

Summary

This Phase 2 trial comparing Bicillin L-A to placebo for chronic plaque-type psoriasis unresponsive to topical medications was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• BICILLIN L-A (PENICILLIN G BENZATHINE)

Snippet

Sponsor: University of Tennessee | Conditions: Psoriasis | Phase 2 | Status: TERMINATED